Search results :

Deferasirox

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: V03AC03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6
Abdominal pain common, 14.1% - 28% x x x x x x
Blood creatinine increased very common x x x x x
Vomiting common, 9.66% - 21.2% x x x x x x
Nausea common, 1.54% - 25.7% 7.14% x x x x x x
Diarrhoea common, 4.55% - 47.4% 1.79% x x x x x x
Rash common, 1.54% - 13.2% 1.79% x x x x x x
Abdominal distension common x
Constipation common x
Dyspepsia common x
Headache common x x x x
Proteinuria common x x x x x x
Pruritus common x
Transaminases increased common x
Creatinine increased 0% - 14.2% x x x x x
Anxiety uncommon x x x x x x
Cholelithiasis uncommon x x x x x x
Dizziness uncommon x x x x x x
Duodenal ulcer uncommon x x x
Oedema uncommon x x x x x x
Fanconi syndrome uncommon x x x
Fatigue uncommon x x x x x x
Body temperature increased uncommon x x x x x x
Gastritis uncommon x x x x x x
Glycosuria uncommon x x x x x x
Hepatitis uncommon x
Gastric ulcer uncommon x x x
Ulcer uncommon x x x
Cataract uncommon x x x x x x
Pigmentation disorder uncommon x x x x x x
Maculopathy uncommon x x x x x x
Sleep disorder uncommon x x x x x x
Pharyngolaryngeal pain uncommon x x x x x x
Hearing impaired uncommon x x x x x x
Gastrointestinal haemorrhage postmarketing, uncommon x x x
Agranulocytosis postmarketing x x x
Alopecia postmarketing x x
Anaphylactic shock postmarketing x x x x x
Anaemia postmarketing x x x x x
Angioedema postmarketing x x x x x
Cytopenia postmarketing x x x
Oesophagitis rare x x x
Gastrointestinal disorder postmarketing x x x x x x
Blood disorder postmarketing x x x
Hypersensitivity postmarketing x x x x x
Immune system disorder postmarketing x x x x x
Renal failure acute postmarketing x x x x x
Hepatic cirrhosis postmarketing x x
Multi-organ failure postmarketing x x
Neutropenia postmarketing x x x
Pancytopenia postmarketing x x x x
Stevens-Johnson syndrome postmarketing x x
Thrombocytopenia postmarketing x x x
Tubulointerstitial nephritis postmarketing x x
Urinary tract disorder postmarketing x x
Urticaria postmarketing x x x x x x
Hepatic failure postmarketing x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Fatal outcomes postmarketing x x
Hepatobiliary disease postmarketing x x
Iron overload postmarketing x
Blood and lymphatic system disorders postmarketing x x
Leukocytoclastic vasculitis postmarketing x x x x x
Pancreatitis acute x
Acute tonsillitis x x x
Arthralgia x x x
Back pain x x x
Mental disorder x
Bronchitis x x x
Infection x x x x x
Cough x x x
Erythema multiforme x x
Eye disorder x
High frequency deafness x
Haemorrhage x
Influenza x x x
Mediastinal disorder x
Nasopharyngitis x x x
Nervous system disorder x
Optic neuritis x x
Pancreatitis x x
Pharyngitis x x x
Henoch-Schonlein purpura x x x x x
Renal failure x
Respiratory tract infection x x x
Rhinitis x x x
Tuberculosis x x
Liver function test abnormal x x x x x
Alanine aminotransferase increased x x x x x
Digestion impaired x
Abdominal pain upper x x x x
Abdominal pain lower x
Hyperkinesia x x x x x
Gastrointestinal symptom NOS x x x x x
Serum creatinine abnormal x
Anaemia NOS aggravated x
Nephropathy toxic x
Ear infection x x x
Ear and labyrinth disorders x
Blood creatinine abnormal x x x x
Serum transaminase increased x x x x x
Insomnia x x x x x
Drug-induced hepatitis x x x x x
Drug fever x x x x x
Lenticular opacities x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

deferasirox / deferasirox

Side effects:63
Source:EMA

DEFERASIROX

Side effects:62
Source:FDA Structured Product Label

DEFERASIROX / EXJADE

Side effects:64
Source:FDA

DEFERASIROX / EXJADE

Side effects:49
Source:FDA

DEFERASIROX / EXJADE

Side effects:62
Source:FDA

DEFERASIROX / EXJADE

Side effects:66
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label